Clinical Independence in the Age of AI and Private Capital

Clinical independence is not a checkbox; it is the foundation that determines whether a healthcare platform can grow sustainably while adhering to the mandate to serve patients. In this episode of "Counsel That Cares," Healthcare Transactions attorney John Saran and oral and maxillofacial surgeon Robert "Bobby" McNeill discuss the increasing focus on the intersection of private equity investment and independent clinical judgment amid accelerated industry consolidation and heightened regulatory scrutiny. Dr. McNeill brings a distinct perspective combining professional medical and dental experience, an MBA in healthcare management, service on the Texas State Board of Dental Examiners and current law school studies. With this background, he emphasizes that even though private capital brings critical infrastructure, technology and operational support, its value is durable only when clinicians retain true authority over patient care, not only in legal documents but also in day-to-day practice, where metrics, financial incentives and emerging technologies such as artificial intelligence (AI) can subtly shape decisions. Throughout the conversation, both speakers reiterate that when clinical independence is not meaningfully preserved in practice, it can affect patient trust, regulatory exposure and overall platform stability.